IP Library Granted Patent US 7,211,389
Granted Patent B2
US 7,211,389 · App. 10/781,989 · Granted May 1, 2007

Method for producing immunoglobulins containing protection proteins and their use

Assignee: The Regents of the University of California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,211,389
App. No.
10/781,989
Granted
May 1, 2007
Kind
B2
Abstract

The immunoglobulins of the present invention are useful therapeutic immunoglobulins against mucosal pathogens such as S. mutans . The immunoglobulins contain a protection protein that protects the immunoglobulins in the mucosal environment. The invention also includes the greatly improved method of producing immunoglobulins in plants by producing the protection protein in the same cell as the other components of the immunoglobulins. The components of the immunoglobulin are assembled at a much improved efficiency. The method of the invention allows the assembly and high efficiency production of such complex molecules. The invention also contemplates the production of immunoglobulins containing protection proteins in a variety of cells, including plant cells, that can be selected for useful additional properties. The use of immunoglobulins containing protection proteins as therapeutic antibodies against mucosal and other pathogens is also contemplated.

Claims (15)

1. A method of producing a transgenic plant expressing an immunoglobulin comprising a protection protein in association with an immunoglobulin heavy chain having at least a portion of an antigen binding domain, wherein the protection protein comprises a portion of SEQ ID NO: 2, 4, 6, 8, or 10, comprising:

a) introducing into a first plant an expression vector containing a nucleotide sequence encoding the protection protein operably linked to a transcriptional promoter,

b) introducing into a second plant an expression vector containing a nucleotide sequence encoding the immunoglobulin heavy chain having at least a portion of an antigen binding domain operably linked to a transcriptional promoter,

c) crossing said first plant and said second plant to produce offspring, and

d) selecting from said offspring a transgenic plant expressing the immunoglobulin comprising the protection protein in association with the immunoglobulin heavy chain having at least a portion of an antigen binding domain.

2. The method of claim 1 , wherein the transgenic plant is a monocot.

3. The method of claim 1 , wherein the transgenic plant is a dicot.

4. The method of claim 3 , wherein the transgenic plant is a tobacco plant.

5. The method of claim 1 , wherein the transgenic plant is an alfalfa plant.

6. The method of claim 1 , further comprising introducing into said transgenic plant an expression vector encoding an immunoglobulin derived light chain having at least a portion of an antigen binding domain operably linked to a transcriptional promoter.

7. The method of claim 1 , further comprising introducing into said first plant an expression vector encoding an immunoglobulin derived light chain having at least a portion of an antigen binding domain operably linked to a transcriptional promoter.

8. The method of claim 1 , further comprising introducing into said second plant an expression vector encoding an immunoglobulin derived light chain having at least a portion of an antigen binding domain operably linked to a transcriptional promoter.

9. The method of claim 1 , further comprising introducing into said transgenic plant an expression vector encoding an immunoglobulin derived J chain having at least a portion of an antigen binding domain operably linked to a transcriptional promoter.

10. The method of claim 1 , further comprising introducing into said first plant an expression vector encoding an immunoglobulin derived J chain having at least a portion of an antigen binding domain operably linked to a transcriptional promoter.

11. The method of claim 1 , further comprising introducing into said second plant an expression vector encoding an immunoglobulin derived J chain having at least a portion of an antigen binding domain operably linked to a transcriptional promoter.

Continuity (5)
Continuation 0971788800 · Nov 20, 2000
Continuation 0931215700 · May 14, 1999
Continuation 0843400000 · May 4, 1995
Continuation 0836739500 · Dec 30, 1994
Related Publication 20050202026A1 · Sep 15, 2005